| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Customized |
|
Still deciding? Get samples of $ !
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Product Name | Ozagrel |
| CAS No. | 82571-53-7 |
| MF | C13H12N2O2 |
| MW | 228.251 |
| Appearance and shape | White powder |
Function
Ozagrel's sodium salt has a powerful anti-thrombotic effect. It is the world's first powerful inhibitor of thromboxane synthase on the market. It is resistant to different inducers (such as collagen, arachidonic acid, ADP, 5- Platelet aggregation caused by HT, etc.) have inhibitory effects, which can inhibit TXA2 synthase and promote the production of PGI2, have anti-platelet aggregation and relieve vasospasm, and can inhibit cerebral thrombosis and cerebral vasospasm. It is mainly used to improve the symptoms of cerebral vascular contracture and concurrent cerebral ischemia after subarachnoid hemorrhage.
Application
It is clinically used to improve cerebral spasm after subarachnoid hemorrhage and cerebral ischemic symptoms accompanied by cerebral spasm, as well as the improvement of dyskinesia accompanying cerebral thrombosis in the acute phase.
){kind=link}